Popular Articles

Taxing Health Benefits Lacking Hill Support
The idea of taxing health care benefits is proving to be a divisive issue for Democrats as they continue to press forward in health overhaul negotiations. "One day after lawmakers returned from a weeklong vacation, the White House and Democratic leadership made a conspicuous effort to assert control over the effort to push health insurance legislation through committees and both houses of Congress over the next five weeks," the Associated Press reports. "While Obama has called for a bipartisan measure, a partisan bill written by and for Democrats is also a possibility, given the size of the party"s majorities in the House and Senate. ò€¦ Nowhere were the challenges of passing legislation more evident than in the Senate. There, several Democratic officials said the party"s leadership told (Sen. Max) Baucus, D-Mont., that they were unhappy with any tax on health care benefits - a key component of bipartisan negotiations - and expressed fears it could lose more votes on their side of the aisle than it gained among Republicans."
pharmacy online
Eurand Successfully Completes Registration Procedure For Paracetamol ODT 250 And 500 Mg In The European Union
Eurand N.V. (NASDAQ: EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies, announced that the Dutch Medicines Evaluation Board (MEB) informed the Company that the Decentralized Procedure (DCP) for registration of Paracetamol 250 and 500 mg Orodispersible Tablets (ODT) in several EU countries has been successfully completed.
News of the day
Red Wine Ingredient Demonstrates Significant Health Benefits: Research Review
The benefits of alcohol are all about moderation. Low to moderate drinking - especially of red wine - appears to reduce causes of mortality, while too much drinking causes multiple organ damage.
Cardiovascular

In A Chemical Library, Yale Researchers Find Keys To Cell Movement

Rummaging through a biotechnology company"s chemical closet, Yale University researchers found two molecules that will allow scientists to better study how cells move. The study in the journal Nature, published online Aug. 2, describes how two small molecules discovered by Cytokinetics Inc. block the action of a key complex that directs the assembly of actin filaments, which produce the force to help cells move. The target of these inhibitors is the Arp2/3 complex, a cellular component so vital that cells die without it. This dependence has made it challenging to learn exactly which cellular processes depend upon the complex. Thomas Pollard, senior author the study and Sterling Professor of Molecular, Cellular & Developmental Biology, said that the inhibitors will allow scientists to turn the complex off and on, helping shed light on the mechanism of cell movement. Pollard noted that cell biologists "desperately need these tools to switch Arp2/3 complex off reversibly without killing the cells." These inhibitors should help scientists determine how nerve cells grow processes to wire the nervous system, embryonic cells migrate to form organs and white blood cells find bacteria. Although the molecules were not useful to Cytokinetics as drug candidates, they are of great scientific interest to biological researchers who study the movement of cells. Pollard"s team determined the crystal structures showing where both of the molecules lodge to block the action of Arp2/3 complex. Pollard serves on the Scientific Advisory Board of Cytokinetics, which found the inhibitors and collaborated on the project. Other Yale authors on the paper include Bradley Nolen, the co-lead author, and CD McCormick. Cytokinetics Inc. and the National Institutes of Health funded the study. Link: Thomas D. Pollard Yale University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):